申请人:Vertex Pharmaceuticals (Canada) Incorporated
公开号:US20130096106A1
公开(公告)日:2013-04-18
Compounds represented by formula:
Wherein X, Y and Z are as defined herein, pharmaceutically acceptable salts thereof, and related compounds, are suitable for use in treating or preventing a Flaviviridae viral infection in a host.
公式代表的化合物:其中X,Y和Z的定义如此,其药学上可接受的盐以及相关化合物,适用于治疗或预防宿主中的黄病毒科病毒感染。